Liver enzymes Flashcards

(48 cards)

1
Q

Bilirubin is a breakdown product of heme (ferroprotoporphyrin IX).

A

The initial steps of bilirubin metabolism occur in reticuloendothelial cells, predominantly in the spleen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

normal values of total serum bilirubin

A

are between 1.0 and 1.5 mg/dL, with 95% of a normal population falling between 0.2 and 0.9 mg/dL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Normal values for the indirect component are

A

between 0.8 and 1.2 mg/dL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The most frequently reported upper limit

A

of normal for conjugated bilirubin is 0.3 mg/dL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The presence of conjunctival icterus

A

suggests a total serum bilirubin level of at least 3.0 mg/dL but does not allow differentiation between conjugated and unconjugated hyperbilirubinemia.

Tea- or cola-colored urine may indicate the presence of bilirubinuria and thus conjugated hyperbilirubinemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the most sensitive markers of acute hepatocellular injury,

A

The serum aminotransferases (also called transaminases),

ALT (formerly serum glutamic pyruvic transaminase, or SGPT)
AST (formerly serum glutamic oxaloacetic transaminase, or SGOT) catalyze the transfer of the α-amino groups of alanine and l-aspartic acid, respectively, to the α-keto group of ketoglutaric acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

a cytosolic enzyme also found in many organs, is present in greatest concentration by far in the liver and is, therefore, a more specific indicator

A

ALT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The differential diagnosis of marked elevations of aminotransferase levels (>1000 U/L)

A

includes viral hepatitis (A to E), toxin- induced liver injury, DILI, ischemic hepatitis, and less commonly, autoimmune hepatitis, acute Budd-Chiari syndrome, ALF caused by Wilson disease, and acute obstruction of the biliary tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If the AST level is less than 300 U/L, a ratio of AST to ALT of more than 2 suggests

A

alcohol- associated liver disease, and a ratio of more than 3 is highly suggestive of alcohol-associated liver disease

ratio results from a deficiency of pyridoxal 5′-phosphate in patients with alcohol- associated liver disease;

ALT synthesis in the liver requires pyridoxal phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When a patient with chronic alcohol-associated liver disease sustains a superimposed liver injury, particularly acetaminophen hepatotoxicity,

A

the aminotransferase levels can be strikingly elevated, yet the AST/ ALT ratio is maintained.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CHRONIC, MILD ELEVATIONS, ALT > AST (<150 U/L OR 5 × NORMAL)

A
Hepatic
α1-Antitrypsin deficiency 
Autoimmune hepatitis
Chronic viral hepatitis (B, C, and D) Hemochromatosis
Medications and toxins
Steatosis and steatohepatitis 
Wilson disease 

Nonhepatic
Celiac disease
Hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SEVERE, ACUTE ELEVATIONS, ALT > AST (>1000 U/L OR > 20-25 × NORMAL)

A

Hepatic
Acute bile duct obstruction
Acute Budd-Chiari syndrome Acute viral hepatitis Autoimmune hepatitis
Drugs and toxins
Hepatic artery ligation Ischemic hepatitis Wilson disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SEVERE, ACUTE ELEVATIONS, AST > ALT (>1000 U/L OR >20-25 × NORMAL)

A

Hepatic
Medications or toxins in a patient with underlying alcohol-associated liver injury

Nonhepatic
Acute rhabdomyolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chronic, mild elevations, AST > ALT (<150 U/L, <5 × normal)

A

Hepatic
Alcohol-associated liver injury (AST/ALT >2:1, AST nearly always <300 U/L)
Cirrhosis

Nonhepatic
Hypothyroidism
Macro-AST Myopathy Strenuous exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The first step in the evaluation of mildly elevated serum aminotransferase levels

A

is to repeat the test to confirm persistence of the elevated value.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The clinical onset of Wilson disease

A

is usually between 3 and 55 years of age; the diagnosis should be considered initially in all patients age 40 or younger and those older than age 40 with aminotransferase elevations that remain unexplained after other causes are excluded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

has a serum half-life of approximately 7 days, and although the sites of degradation are unknown,

A

ALP

clearance of ALP from serum is independent of either patency of the biliary tract or functional capacity of the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

In a person with isolated elevation of the serum ALP level,

A

the serum GGTP or 5′NT is used to distinguish a liver from a bone origin of the ALP elevation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

elevated serum GGTP level

A

has high sensitivity for hepatobiliary disease, its lack of specificity limits its clinical utility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

GGTP is elevated in patients

A

taking antiepileptics, including phenytoin, carbamazepine, valproic acid, and barbiturates, as well as some drugs used in antiretroviral therapy, such as non-nucleoside reverse transcriptase inhibitors and the protease inhibitor abacavir.

21
Q

PBC is a classic autoimmune disease.

A

immunologic injury is characterized by T cell–mediated destruction of the intrahepatic bile ducts.
Although predominantly a disease of middle- aged women, with a median age at diagnosis of approximately 50 years, 5% to 10% of affected patients are men.

22
Q

Albumin

A

The average adult pro- duces approximately 15 g/day and has 300 to 500 g of albumin distributed in body fluids.

The liver has the ability to double the rate of synthesis in the setting of rapid albumin loss or a dilutional decrease in the serum albumin concentration

half-life of albumin is 14 to 21 days; there are multiple sites of degradation, including skin, muscle, liver, and kidney, as well as leakage in the gut.

23
Q

Bland cholestasis

A

Anabolic steroids

Estrogens

24
Q

Cholestatic hepatitis

A

Angiotensin-converting enzyme inhibitors: captopril, enalapril Antimicrobials: amoxicillin-clavulanic acid, ketoconazole Azathioprine
Chlorpromazine
NSAIDs: sulindac, piroxicam

25
Granulomatous hepatitis
Allopurinol Antibiotics: sulfonamides Antiepileptics: carbamazepine, phenytoin Cardiovascular agents: hydralazine, procainamide, quinidine Phenylbutazone
26
Vanishing bile duct syndrome
``` Amoxicillin-clavulanic acid Chlorpromazine Dicloxacillin Flucloxacillin Macrolides ```
27
Extrahepatic Causes of Cholestatic Liver Enzymes in Adults | INTRINSIC
AIDS cholangiopathy Ampullary cancer Ascariasis Autoimmune pancreatitis Cholangiocarcinoma Choledocholithiasis CMV Cryptosporidiosis Immune-mediated duct injury Infections Malignancy Microsporidiosis Parasitic infections PSC
28
EXTRINSIC
``` Gallbladder cancer Malignancy Metastases, including portal adenopathy from metastases Mirizzi syndrome Pancreatic cancer Pancreatic pseudocyst Pancreatitis ```
29
Serum albumin levels less than 3 g/dL in a patient with newly diagnosed hepatitis
should raise suspicion of a chronic process. Serum albumin is an excellent marker of hepatic synthetic function in patients with chronic liver disease and cirrhosis
30
___ is the end result of a complex series of enzymatic reactions involving clotting factors, all of which are produced in the liver except factor VIII, which is produced by vascular endothelial cells
Clotting
31
Factors involved in the synthesis of prothrombin
include II, V, VII, and X.
32
used to express the degree of anticoagulation on warfarin therapy.
The INR
33
A prolonged prothrombin time can be caused by a number of conditions besides reduced hepatic synthetic function:
congenital deficiency of clotting factors, vitamin K deficiency (vitamin K is required for normal functioning of factors II, VII, IX, and X), and DIC.
34
can be identified by measuring a factor VIII level in serum;
DIC the level is decreased in DIC and normal or increased in liver disease.
35
allows an assessment of current hepatic synthetic function; factor VII has the shortest serum half-life (6 hours) of all the clotting factors.
The prothrombin time
36
Used to allocate donor organs for LT
The INR, along with total serum bilirubin and creatinine levels, are components of the MELD score
37
is not an accurate measure of bleeding risk in patients with cirrhosis, because it assesses only the activity of procoagulant clotting factors, not anticoagulant factors such as protein C and antithrombin, the production of which is also reduced in cirrhosis.
The prothrombin time
38
a glucosaminoglycan produced in mesenchymal cells and widely distributed in the extracellular space.
Hyaluronic acid A fasting hyaluronic acid level greater than 100 mg/L had a sensitivity of 83% and specificity of 78% for the detection of cirrhosis in patients with a variety of chronic liver diseases
39
Indocyanine Green Clearance
``` Indocyanine green (ICG) is a nontoxic dye that is cleared exclusively by the liver; 97% of an administered dose (0.5 mg/kg given as an IV bolus) is excreted unchanged into bile. ``` can be measured directly by spectrophotometry.
40
Possible uses of ICG
include the assessment of hepatic dysfunction, measurement of hepatic blood flow, and prediction of clinical outcomes in patients with liver disease.
41
has been studied as a | measure of functional hepatic mass.
Galactose Elimination Capacity given as a single IV bolus (0.5 g/kg)
42
Caffeine clearance tests
quantify functional hepatic capacity by assessing the activity of cytochrome P450 1A2, N-acetyltransferase,and xanthine oxidase ``` given orally (200 to 366 mg), and levels are measured in blood, urine, saliva, breath, or scalp hair. ```
43
Lidocaine Metabolite Formation
Lidocaine is metabolized to its major metabolite monoethyl-glycinexylidide (MEGX) by the hepatic cytochrome P450 sys- tem.
44
BILE ACIDS
synthesized from cholesterol in hepatocytes, conjugated to glycine or taurine, and secreted into bile
45
are sensitive but nonspecific indicators of hepatic dysfunction and allow some quantification of functional hepatic reserve.
Serum bile acids
46
Acetaminophen Toxicity
The dose of acetaminophen exceeds 15 g, almost 4 times the recommended daily dose, in 80% of cases. Acetaminophen doses within the therapeutic range (≤4 g/day) can be sufficient to cause liver injury in susceptible persons, such as those who use ethanol chronically.
47
The King’s College criteria
identify patients with a poor prognosis from acetaminophen-induced liver injury: those with an arterial pH below 7.3 or those with an INR above 6.5 serum creatinine level above 3.4 g/dL stage 3 to 4 hepatic encephalopathy
48
The score has subsequently been validated as an accurate predictor of survival in patients with advanced liver disease.
The MELD score incorporates 3 objective variables into a mathematical formula: 9.57 × loge(creatinine) + 3.78 × loge(total bilirubin) + 11.2 × loge(INR) + 6.43. The working range is 6 to 40, and the score has been shown to correlate with mortality in patients undergoing surgery other than LT, including hepatic resection, other abdominal procedures, and cardiac surgery